Bond Bristol Myers Squibb 1.75% ( XS1226748512 ) in EUR

Bristol Myers Squibb

119.70 % ▲

United States

XS1226748512 ( in EUR )

1.75% per year ( payment 1 time a year)

14/05/2035

Prospectus brochure in PDF format

15/05/2027 ( In 261 days )

Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis.

Bristol Myers Squibb's EUR-denominated bond (ISIN: XS1226748512), maturing on May 14, 2035, currently trades at 87.51% of its face value, offering a 1.75% coupon rate with annual payments.

Date	Clean price
10/03/2026	86.35%
05/01/2026	84.42%
06/11/2025	85.84%
11/09/2025	85.90%
18/07/2025	85.70%
19/05/2025	84.76%
04/03/2025	86.69%
12/01/2025	84.98%
15/11/2024	87.51%
27/09/2024	87.37%
10/08/2024	86.74%
07/08/2024	100.00%
20/02/2024	85.47%
19/08/2023	92.85%
26/07/2023	92.85%
02/07/2023	92.85%
08/06/2023	92.85%
15/05/2023	92.85%
21/04/2023	92.85%
28/03/2023	92.85%
04/03/2023	92.85%
09/02/2023	92.85%
17/01/2023	92.85%
25/12/2022	92.85%
02/12/2022	92.85%
09/11/2022	92.85%
19/10/2022	92.85%
28/09/2022	92.85%
07/09/2022	92.85%
17/08/2022	92.85%
27/07/2022	92.85%
06/07/2022	92.85%
15/06/2022	92.85%
25/05/2022	92.85%
04/05/2022	92.85%
19/04/2022	95.45%
04/04/2022	99.16%
20/03/2022	98.96%
05/03/2022	102.42%
17/02/2022	101.92%
30/01/2022	108.55%
12/01/2022	109.52%
26/12/2021	111.74%
10/12/2021	113.39%
23/11/2021	112.32%
09/11/2021	113.58%
26/10/2021	111.66%
12/10/2021	110.93%
29/09/2021	112.65%
10/09/2021	114.63%
27/08/2021	115.57%
15/08/2021	117.05%
03/08/2021	117.34%
22/07/2021	116.19%
09/07/2021	115.29%
24/06/2021	113.17%
10/06/2021	114.37%
23/05/2021	110.94%
06/05/2021	113.97%
16/04/2021	114.73%
30/03/2021	114.35%
13/03/2021	115.19%
25/02/2021	115.69%
09/02/2021	118.69%
27/01/2021	120.67%
15/01/2021	119.94%
04/01/2021	120.71%
22/12/2020	120.49%
08/12/2020	120.70%
25/11/2020	120.45%
09/11/2020	119.38%
28/10/2020	119.70%